首页> 外文会议>International Conference on Environmental Science and Technology >OCCURRENCE AND ENVIRONMENTAL RISK ASSESSMENT OF PHARMACEUTICALS IN SEWAGE SLUDGE AND SOIL - A CRITICAL REVIEW
【24h】

OCCURRENCE AND ENVIRONMENTAL RISK ASSESSMENT OF PHARMACEUTICALS IN SEWAGE SLUDGE AND SOIL - A CRITICAL REVIEW

机译:污水污泥和土壤药物的发生和环境风险评估 - 批判性综述

获取原文

摘要

Pharmaceuticals administered for treating and preventing numerous diseases are only partially assimilated in human body and the remaining part is excreted through urine and feces and occurs in urban wastewater. This is conveyed to a municipal wastewater treatment plant where activate sludge system is the most adopted treatment due to its simplicity and economical convenience. Unfortunately it is not able to efficiently remove these micropollutants and other persistent compounds from wastewater.Removal efficiency of pharmaceuticals has been extensively investigated in the last years with respect to the liquid phase, whereas their fate in activated sludge process and their partitioning between aqueous and solid phases has been less frequently studied. It should be very important to investigate the presence of these compounds in the sewage sludge and the potential environmental risk posed by their residues on terrestrial organisms as sludge may be applied in agriculture.This study collects and discusses available literature data on the occurrence of about 100 pharmaceuticals in untreated and treated sewage sludges derived from urban wastewater treatment plants in different countries. It was found that variability range of concentration varies depending on pharmaceuticals and on adopted treatment level. This is the case of ciprofloxacin and triclosan. Attempts to correlate pharmaceutical concentrations in sludge and pharmaceutical properties were carried out.Moreover, environmental risk posed by pharmaceuticals in sludge and soil is also evaluated through the Risk Quotient approach. Based on this study, the most critical compounds in sludge and soil are antibiotics and hormones, respectively. Finally, a comparison between risk posed by sludge, land disposal and that previously assessed by secondary effluent is reported and discussed. This allows to identify the most critical compounds in the two matrixes.
机译:用于治疗和预防众多疾病的药物仅在人体中部分同化,其余部分通过尿液和粪便排出并发生在城市废水中。这将传送到市政废水处理厂,其中激活污泥系统是由于其简约和经济的便利而采用的最多措施。不幸的是,它无法有效地从废水中有效地去除这些微渗透物和其他持续的化合物。在液相中,在过去几年中,药物的效率已经广泛研究,而它们在活性污泥过程中的命运及其在水性和固体之间分配阶段已经不太频繁地研究过。研究这些化合物在污水污泥中的存在以及作为污泥的陆地生物的残留物占据的潜在环境风险应该是非常重要的,因为可以在农业中申请。本研究收集并讨论了大约100个发生的可用文献数据未经治疗和处理过的污水污染的药品源于不同国家的城市废水处理厂。发现浓度的可变性范围根据药物和采用的治疗水平而变化。这是CiProfloxacin和Triclosan的情况。进行了将药物浓度与污泥和药物性质相关联的试图。污泥和土壤中药物造成的环境风险也通过风险商评估。基于这项研究,污泥和土壤中最关键的化合物分别是抗生素和激素。最后,报告并讨论了污泥,土地处理和先前评估的风险之间的比较,并讨论了次要排出量。这允许识别两个矩阵中最关键的化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号